A Systematic Review and Meta-analysis of the Risk of Diarrhea Associated With Vandetanib Treatment in Carcinoma PatientsJuly 21, 2016
[OncoTargets and Therapy] This research examines overall risks of all-grade and high-grade diarrhea during vandetanib treatment, to gain a better understanding of its prediction and management.
The 2016 WHO Classification of Infiltrating Gliomas alters diagnostic criteria, providing the basis for clinical trial inclusion or exclusion based on an integrated diagnosis and setting the stage for all future research, according to a summary of 4 posters related to CNS biomarkers presented at the ASCO 2016 Annual Meeting.
The addition of chemotherapy to radiation therapy prolonged survival in adults with grade 2 glial brain tumors.
Adding panobinostat to radiotherapy appears safe, tolerable, and has preliminary efficacy for treating recurrent high-grade gliomas.
This technique, which does not use pharmaceutical sedatives, can ease the perioperative discomfort and anxiety experienced by some patients undergoing fully awake craniotomy to remove glioma.
Detailed new information about diffuse glioma has come from an international collaborative study, raising hopes for improved clinical outcomes from a better understanding of the disease.
Glioma Cells Self-organize Into Streams of Cells That Follow a Mathematically Predicted Pattern to Build Brain TumorsDecember 29, 2015
Brain tumor cells can self-organize, according to new research. Glioma cells build tumors by self-organizing into streams 10 to 20 cells wide that obey a mathematically predicted pattern for autonomous agents flowing together.
A signaling pathway present in most organisms suppresses the formation of specific types of brain tumor.
Five new genetic variants associated with glioma have been identified in the biggest ever study of DNA in patients within this population.
It is feasible to treat seizures with a combination of non-oral benzodiazepines in the end-of-life phase of patients with gliomas.
For children with high-grade gliomas, the chances of survival are improved when surgery is successful in eliminating all visible cancer.
Classification system offers precise determination of effectiveness of surgical resection of gliomasAugust 11, 2015
A new procedure for analyzing radiologic imaging scans increases the chance to accurately predict the course of malignant gliomas.
A tumor's DNA composition plays a key role in whether a glioma may transform into a more serious glioblastoma.
New evidence indicates that combining chemotherapy with radiation therapy may be the best option for people with a low-grade form of brain cancer.
Certain forms of birth control may increase the risk for developing a glioma, a rare brain cancer.
A chemotherapy regimen of procarbazine, lomustine (CCNU), and vincristine (PCV) administered after radiation therapy improved both progression-free survival and overall survival in adults with low-grade gliomas.
Risk of brain cancer is three times higher after 25 years or more of mobile phone use.
A new web-based program will provide a simple, free way for health care providers to determine which brain tumor cases require testing for a genetic mutation.
Researchers have identified a genetic mutation in brain cancer tumor cells that plays a role in both the growth and the death of the cell.
New mutations in pediatric brain tumors known as high-grade gliomas have been identified, and most often occur in the youngest patients.
The first large-scale cohort study of the long-term survival of children treated for low-grade gliomas found that almost 90% are alive 20 years later.
Receiving a chemotherapy regimen following the completion of radiation therapy resulted in longer survival in adults with low-grade gliomas compared with those who received radiation therapy alone.
A known genetic pathway is active in many difficult-to-treat pediatric brain tumors known as low-grade gliomas. This finding offers a potential new target for the treatment of these cancers.
The amino acid imaging agent O-(2-[18F]-fluroethyl)-L-tyrosine (F-18 FET) has diagnostic benefit for imaging pediatric gliomas when conventional MRI is ineffective.
First-line temozolomide did not offer improvements over radiotherapy for high-risk, low-grade glioma, according to a large, international, randomized trial. The two treatment strategies did not have a statistically significant difference for progression-free survival, although radiotherapy was numerically favored.
Patients' CpG island methylator phenotype (CIMP) status and methylation of the O-6-methylguanine-DNA methyltransferase (MGMT) promoter are the most informative in identifying patients with grade III glioma who might benefit from adding procarbazine, CCNU, and vincristine (PCV) to radiation therapy
Genetic material secreted by bone marrow cells was used to reduce glioma tumor volume in a recent study.
Adipose tissue may provide a more efficient, less costly, and less invasive source of mesenchymal stem cells (MSCs) than bone marrow.
ELTD1, a protein linked with angiogenesis, is the strongest candidate for a significant association with glioma out of nearly 200 possible markers.
Imaging with 18F-FLT positron emission tomography provides tumor-specific details accurately and noninvasively in persons with gliomas.
Sign Up for Free e-newsletters
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC
- Novel Approach Can Improve Both Colorectal Cancer Screening Outcomes and Adherence
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|